Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I think it's a good sign that...

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Feb 28, 2024 8:37am

216 Views

Post# 35903330

RE:RE:I think it's a good sign that...

Hate to be a downer but I'm pretty sure that this is a catch up SEDAR filing. I recall that with one of the PP's in 2023, I noticed that there was a missing insider filing for RDW. The details also match as far as price 0.22 per share plus 0.28 warrants. I'd have to go back and find which one it was but I suspect that this is TLT realizing that one of many SEDAR filings was missed and playing catch up.

I don't think there is a mechanism for RDW to buy shares like that outside of an offering or on the open exchange.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages